Your browser doesn't support javascript.
loading
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil, Vijay Maruti; Noronha, Vanita; Joshi, Amit; Agarwal, Jaiprakash; Ghosh-Laskar, Sarbani; Budrukkar, Ashwini; Murthy, Vedang; Gupta, Tejpal; Mahimkar, Manoj; Juvekar, Shashikant; Arya, Supreeta; Mahajan, Abhishek; Agarwal, Archi; Purandare, Nilendu; Rangarajan, Venkatesh; Balaji, Arun; Chaudhari, Sameer Vasant; Banavali, Shripad; Kannan, Sadhana; Bhattacharjee, Atanu; D'Cruz, Anil K; Chaturvedi, Pankaj; Pai, Prathamesh S; Chaukar, Devendra; Pantvaidya, Gouri; Nair, Deepa; Nair, Sudhir; Deshmukh, Anuja; Thiagarajan, Shivakumar; Mathrudev, Vijayalakshmi; Manjrekar, Aparna; Dhumal, Sachin; Maske, Kamesh; Bhelekar, Arti Sanjay; Nawale, Kavita; Chandrasekharan, Arun; Pande, Nikhil; Goel, Alok; Talreja, Vikas; Simha, Vijai; Srinivas, Sujay; Swami, Rohit; Vallathol, Dilip Harindran; Dsouza, Hollis; Shrirangwar, Sameer; Turkar, Siddharth; Abraham, George; Thanky, Aditi Harsh; Patel, Usha; Pandey, Manish Kumar.
Afiliación
  • Patil VM; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Agarwal J; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Ghosh-Laskar S; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Budrukkar A; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Murthy V; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Gupta T; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Mahimkar M; Mahimkar Laboratory, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India.
  • Juvekar S; Department of Radiology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Arya S; Department of Radiology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Mahajan A; Department of Radiology, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Agarwal A; Department of Nuclear Medicine, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Purandare N; Department of Nuclear Medicine, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Rangarajan V; Department of Nuclear Medicine, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Balaji A; Department of Speech and Therapy, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Chaudhari SV; Biocon Ltd, Bengaluru, India.
  • Banavali S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Kannan S; Department of Biostatistics, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India.
  • Bhattacharjee A; Department of Epidemiology, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India.
  • D'Cruz AK; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Chaturvedi P; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Pai PS; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Chaukar D; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Pantvaidya G; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Nair D; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Nair S; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Deshmukh A; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Thiagarajan S; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India.
  • Mathrudev V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Manjrekar A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Dhumal S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Maske K; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Bhelekar AS; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Nawale K; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Chandrasekharan A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Pande N; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Goel A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Talreja V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Simha V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Srinivas S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Swami R; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Vallathol DH; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Dsouza H; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Shrirangwar S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Turkar S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Abraham G; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Thanky AH; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Patel U; Mahimkar Laboratory, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India.
  • Pandey MK; Mahimkar Laboratory, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India.
Cancer ; 125(18): 3184-3197, 2019 09 15.
Article en En | MEDLINE | ID: mdl-31150120
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cisplatino / Anticuerpos Monoclonales Humanizados / Quimioradioterapia / Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cisplatino / Anticuerpos Monoclonales Humanizados / Quimioradioterapia / Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos